溴隐亭诱导垂体腺瘤发生自噬依赖性细胞死亡
该研究在37例泌乳素瘤石蜡切片中检测LC3表达,并用溴隐亭和/或雷帕霉素处理GH3与MMQ细胞,发现BRC治疗患者肿瘤LC3显著表达,BRC可诱导细胞死亡、细胞周期阻滞、LC3-I向LC3-II转化增加及泌乳素分泌减少,结论为BRC处理的垂体腺瘤细胞主要发生自噬性细胞死亡而非凋亡。
要点
- BRC治疗患者的泌乳素瘤LC3显著表达,未治疗者及正常组织阴性。
- 60 μM BRC处理24小时使MMQ细胞死亡达50%,GH3细胞需110 μM。
- BRC使细胞周期阻滞于G0-G1期和S期,并降低泌乳素分泌。
核心结论
- BRC处理的垂体腺瘤细胞主要发生自噬性细胞死亡而非凋亡。
研究设计与样本
- 从37例泌乳素瘤石蜡包埋组织切片中随机选取切片行免疫组化检测LC3。
- 用BRC和/或雷帕霉素处理GH3和MMQ细胞,检测细胞活力、细胞周期、泌乳素分泌及蛋白表达。
主要发现
- LC3在仅用BRC治疗的泌乳素瘤中显著表达,在正常组织和未用BRC治疗的泌乳素瘤中表达阴性。
- 60 μM BRC处理24小时使MMQ细胞死亡达50%,而GH3细胞需110 μM BRC才产生类似效果。
- 细胞周期阻滞于G0-G1期和S期,随浓度和时间增加LC3-I向LC3-II转化率升高、泌乳素分泌减少。
- Bcl-2和BAX表达降低。
- 雷帕霉素联合低浓度BRC与高浓度BRC处理的MMQ细胞在细胞活力、泌乳素水平和G0-G1期细胞上相似,但前者更有效增加LC3-I向LC3-II转化率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bromocriptine (BRC) is effective in patients with prolactinoma. However, the cytotoxic mechanism of BRC remains unknown. METHODS: Slices for immunohistochemical pathology were randomly selected from 37 paraffin-embedded prolactinoma tissue sections. LC3 was detected by immunohistochemistry. GH3 and MMQ cells were treated by BRC and/or rapamycin (RAPA). Cell viability and the cell cycle were measured by CCK-8 and flow cytometry, respectively. Enzyme-linked immunosorbent assay measured prolactin secretion. Protein expression was detected by Western blot or immunofluorescence. RESULTS: LC3 was significantly expressed in prolactinoma in which patients were treated exclusively with BRC. LC3 expression was negative in normal tissues and prolactinoma in which patients were not treated with BRC. Treatment with 60 μM BRC for 24 hours induced cell death in MMQ cells by up to 50%. However, 110 μM BRC was required to produce a similar effect in GH3 cells. The cell cycle was arrested at the G0-G1 phase and S phase. As the concentration and time increased, the conversion ratio of LC3-I to LC3-II increased and prolactin secretion decreased. In addition, Bcl-2 and BAX expression was decreased. The cell viability, prolactin level, and G0-G1 cells are similar in MMQ cells treated with RAPA and a low concentration of BRC and MMQ cells treated with a high concentration of BRC. Compared with the effects of a high concentration of BRC, treatment with RAPA and a low concentration of BRC effectively increase the conversion rate of LC3-I to LC3-II. CONCLUSION: BRC-treated pituitary adenoma cells mainly underwent autophagic cell death rather than apoptosis.
引用
- Geng X, Ma L, Li Z, et al. Bromocriptine Induces Autophagy-Dependent Cell Death in Pituitary Adenomas. World Neurosurg. 2017. PMID: 28137551. doi:10.1016/j.wneu.2017.01.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。